Cytal Burn Matrix 10x15 cm. Product ID: BMM1015. Recall
Cytal Burn Matrix 10x15 cm. Product ID: BMM1015.
FDA recall Class II
Ongoing
FDA lists this Class II recall for Cytal Burn Matrix 10x15 cm. Product ID: BMM1015.. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-1820-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Mar 19, 2026
- FDA report date
- Apr 22, 2026
- Quantity in commerce
- 226 units
- Distribution
- See key details
- FDA cause
- Under Investigation by firm
What is being recalled?
Cytal Burn Matrix 10x15 cm. Product ID: BMM1015.
Affected model & UDI checker
Search the exact identifiers published for Z-1820-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| Not specified | Cytal Burn Matrix 10x15 cm. Product ID: BMM1015. | Check source notice | 00386190001110 |
FDA code information
Product ID: BMM1015. UDI-DI: 00386190001110. Lot Numbers: 7579681, 7582225, 7582227, 7583933, 7591942, 7591944, 7583935, 7593018, 7594284, 7593013.
Why was this product recalled?
Increased rate of out-of-specification endotoxin results.
What actions did Integra LifeSciences Corp. (NeuroSciences) take?
Integra LifeSciences notified consignees on about 03/19/2026 via letter. Consignees were instructed to identify any affected units on hand and remove them immediately from service and quarantine them, complete and return the Acknowledgment Form and arrange for the return of affected units. Consignees were also instructed to forward to all affected personnel who utilize the product so they are aware of the recall and can identify any affected product that may remain in clinical areas. Distributors were instructed to identify any affected units on hand and remove them immediately from service and quarantine them, complete and return the Acknowledgment Form and arrange for the return of affected units. Distributors were also instructed to check customer traceability records and notify them if they have any shipments with affected units. They requested to modify the acknowledgement form to provide to customers, collect completed response forms and provide those numbers in the distributor reply form. Integra LifeSciences sent a second notification letter on about 03/20/2026, which updated the lot numbers affected. Consignees were asked to disregard the previous letter and replace it with the updated one. Directions for consignees and distributors did not change.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-1820-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 21, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 21, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology